Tag results:
induced pluripotent stem cells
Organoid News
Attenuation of SARS-CoV-2 Infection by Losartan in Human Kidney Organoids
[iScience] Using iPSC derived-kidney organoids, SARS-CoV-1, SARS-CoV-2 and MERS-CoV tropism, defined by the paired expression of a host receptor and protease, was identified primarily amongst proximal tubule cells.
Muscle Cell News
Generating 3D Human Cardiac Constructs from Pluripotent Stem Cells
[Ebiomedicine] Scientists discuss the advantages and limitations of 2D human pluripotent stem cell (hPSC)-cardiomyocyte system, and introduce the recent development of three-dimensional culture platforms derived from hPSCs.
Organoid News
Kidney Organoids Recapitulate Human Basement Membrane Assembly in Health and Disease
[eLife] Researchers investigated the dynamics of basement membrane assembly in human pluripotent stem cell-derived kidney organoids.
Pulmonary Cell News
Metabolomic Profiling of Human Pluripotent Stem Cell Differentiation into Lung Progenitors
[iScience] Researchers found that the metabolites most enriched during the differentiation from pluripotent stem cell to lung progenitor cell, regardless of cell line, were sphingomyelins and phosphatidylcholines, two important lipid classes in lung development.
ESC & iPSC News
Inducing Somatic Cells into Pluripotent Stem Cells Is an Important Platform to Study the Mechanism of Early Embryonic Development
[Molecular Reproduction and Development] Scientists introduce the research advance of both somatic cell reprogramming and early embryonic development, indicating that the mechanisms of iPSCs also shares common features with that of early embryonic development in several aspects.
Neural Cell News
Antisense Oligonucleotides as a Potential Treatment for Brain Deficits Observed in Myotonic Dystrophy Type 1
[Gene Therapy] The authors indicated that the IONIS 486178 antisense oligonucleotide (ASO) targeted mutant DMPK mRNAs in the brain and strongly supported the feasibility of a therapy for dystrophia myotonica type 1 patients based on the intrathecal injection of an ASO.